Zolpidem Postmarketing Study in Adolescent Patients With Insomnia

Zolpidem Postmarketing Clinical Study: A Double Blind, Placebo Controlled Group Comparative Trial in the Adolescent Patients With Insomnia

To investigate the efficacy and safety of zolpidem for pediatric insomniacs in a randomized double blind-controlled trial

Inclusion Criteria:

• patients diagnosed as having nonorganic insomnia of nonorganic sleep disorder in ICD10
• patients whose age at the time of obtaining consent is 12 years or over and 18 years or below

Exclusion Criteria:

• patients with schizophrenia or manic-depressive illness
• patients with insomnia caused by physical diseases
• patients having a history of hypersensitivity to zolpidem
• patients with attention-deficit hyperactivity disorder